LMP1 mimics a constitutively activated tumor necrosis factor receptor, and induces transformation and promotes tumor progression by activating the NF-κB transcription factor pathway, the MAP kinase cascade, and the PI3K/AKT pathway in NPC cells32–34. The gene discussed is NFKB1; the disease is neoplasm.